Dare Bioscience (DARE) EBT (2016 - 2026)
Dare Bioscience's (DARE) quarterly EBT came in at -$1.6 million in Q4 2025, up 69.4% YoY from -$966372.6 in Q4 2024, and up 71.69% on a QoQ basis from -$5.8 million in Q3 2025.
Dare Bioscience (DARE) EBT (2016 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 10 years of EBT data on file, last reported at -$1.6 million in Q4 2025.
- Quarterly EBT rose 69.4% year-over-year to -$1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$20.4 million (up 15.04% YoY) and the FY2025 annual result came in at -$127.3 million, up 8.41% from the prior year.
- EBT grew to -$1.6 million in Q4 2025, from -$5.8 million in the prior quarter.
- In the past five years, EBT ranged from a high of $304322.0 in Q2 2022 to a low of -$16.3 million in Q4 2022.
- A 5-year average of -$7.4 million and a median of -$7.4 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT soared 103.28% — and 2023, when it slumped 3088.4%.
- Tracing DARE's EBT over 5 years: stood at -$9.7 million in 2021, then slumped by 68.7% to -$16.3 million in 2022, then jumped by 65.82% to -$5.6 million in 2023, then rose by 3.99% to -$5.3 million in 2024, then soared by 69.4% to -$1.6 million in 2025.
- The last three EBT figures came in at -$1.6 million (Q4 2025), -$5.8 million (Q3 2025), and -$5.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Dare Bioscience | 11.91 Mn | -705,728.22 | -132,343.00 | -2.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.89 Mn |
| Dec 31, 2025 | -1.64 Mn |
| Sep 30, 2025 | -5.78 Mn |
| Jun 30, 2025 | -5.95 Mn |
| Mar 31, 2025 | -7.00 Mn |
| Dec 31, 2024 | -5.35 Mn |
| Sep 30, 2024 | -4.91 Mn |
| Jun 30, 2024 | -7.58 Mn |
| Mar 31, 2024 | -6.14 Mn |
| Dec 31, 2023 | -5.57 Mn |
| Sep 30, 2023 | -8.50 Mn |
| Jun 30, 2023 | -9.09 Mn |
| Mar 31, 2023 | -8.49 Mn |
| Dec 31, 2022 | -16.30 Mn |
| Sep 30, 2022 | -7.22 Mn |
| Jun 30, 2022 | 304,322.00 |
| Mar 31, 2022 | -8.52 Mn |
| Dec 31, 2021 | -9.66 Mn |
| Sep 30, 2021 | -12.79 Mn |
| Jun 30, 2021 | -9.28 Mn |